Global 23-Valent Pneumococcal Polysaccharide Vaccine Market to Reach 4550 million USD by 2025 says a Latest Research Report

This report studies the global 23-Valent Pneumococcal Polysaccharide Vaccine market status and forecast, categorizes the global 23-Valent Pneumococcal Polysaccharide Vaccine market size (value & volume) by manufacturers, type, application, and region.

Pune, India - June 13, 2018 /MarketersMedia/ —

23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months. North America is the largest supplier and consumption market of 23-Valent Pneumococcal Polysaccharide Vaccine, with a production market share nearly 70% and sales market share nearly 28% in 2015. Because Sanofipasteur, a competitor from Europe, transferred its vaccine type gradually, the production market share of North America in the world has enjoyed a dramatic increase.

Access more report details at: https://www.themarketreports.com/report/global-23-valent-pneumococcal-polysaccharide-vaccine-market-research-report-2018

Key companies profiled in this report are MSD, Sanofipasteur, CDIBP and others in terms of Company Basic Information, Manufacturing Base, Sales Area, Competitors, Product Category, Application, Specification, Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

The study objectives of this report are:
• To analyze and study the global 23-Valent Pneumococcal Polysaccharide Vaccine sales, value, status (2013-2017) and forecast (2018-2025).
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/984978

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Single Dose Vial
• Pre-filled Syringe

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• For Children (2-10)
• For Person (10-64)
• For The Old (≥65)

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/984978

Contact Info:
Name: Shirish Gupta
Email: [email protected]
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/global-23-valent-pneumococcal-polysaccharide-vaccine-market-to-reach-4550-million-usd-by-2025-says-a-latest-research-report/359614

For more information, please visit https://www.themarketreports.com/report/global-23-valent-pneumococcal-polysaccharide-vaccine-market-research-report-2018

Source: MarketersMedia

Release ID: 359614